Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

NCT05753215 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Bone Infection
Joint Infection
Bone and Joint Infection

Interventions

DRUG: Omadacycline Pill
DRUG: Standard of Care

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Collaborators

[object Object]
[object Object]